Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,685 | 35,526 | 43,977 | 32,848 | 14,042 |
| Marketable Securities | N/A | 0 | 0 | 19,088 | 11,625 |
| Receivables | 1,370 | 1,453 | 1,147 | 1,113 | 1,406 |
| Inventories | 4,433 | 5,447 | 3,897 | 2,663 | 3,812 |
| TOTAL | $35,388 | $43,834 | $50,916 | $56,613 | $31,696 |
| Non-Current Assets | |||||
| PPE Net | 2,291 | 2,634 | 3,740 | 3,480 | 3,539 |
| Intangibles | 484 | 5,553 | 5,716 | 758 | 778 |
| Other Non-Current Assets | 5,755 | 7,207 | 10,426 | 9,949 | 11,335 |
| TOTAL | $8,530 | $15,394 | $19,882 | $14,187 | $15,652 |
| Total Assets | $43,918 | $59,228 | $70,798 | $70,800 | $47,348 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 36 | 1,140 | 1,141 | 1,141 |
| Accounts payable and accrued liabilities | 3,702 | 5,055 | 5,222 | 3,444 | 4,185 |
| Other current liabilities | 264 | 264 | 264 | 264 | 263 |
| TOTAL | $5,040 | $6,489 | $7,651 | $5,617 | $6,314 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 78 | 87 | 96 | 2,105 |
| Deferred Revenues | N/A | N/A | 63 | 63 | 8 |
| Other Non-Current Liabilities | 7,957 | 13,099 | 20,542 | 19,761 | 10,667 |
| TOTAL | $7,682 | $12,516 | $20,468 | $19,480 | $12,482 |
| Total Liabilities | $12,722 | $19,005 | $28,119 | $25,097 | $18,796 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 555 | 555 | 554 | 533 | 533 |
| Common Shares | 63 | 63 | 63 | 62 | 54 |
| Retained earnings | -226,485 | -217,203 | -215,027 | -209,767 | -211,825 |
| Other shareholders' equity | 103 | 354 | 1,027 | 255,408 | 827 |
| TOTAL | $31,196 | $40,223 | $42,679 | $45,703 | $28,552 |
| Total Liabilities And Equity | $43,918 | $59,228 | $70,798 | $70,800 | $47,348 |